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ABSTRACT  The results presented here show that disruption  of the microtubule  network acts 
synergistically with cAMP-elevating  agents to stimulate  the entry  into  DNA synthesis of 3T3 
cells.  Antimicrotubule  agents and  increased  cAMP  levels  require  an  additional  growth-pro- 
moting factor for inducing initiation of DNA synthesis; such requirement can be furnished by 
insulin,  vasopressin,  epidermal  growth  factor,  platelet-derived  growth  factor,  or fibroblast- 
derived  growth  factor.  The  involvement  of  the  microtubules  is  indicated  by  the  fact  that 
enhancement of the  DNA synthetic response was demonstrated with  the chemically  diverse 
agents colchicine,  nocodazole, vinblastine, or demecolcine, all  of which elicited  the response 
in a dose-dependent manner. We verified  that colchicine and nocodazole, at the doses used 
in  this study, induced  microtubule  disassembly in  the absence as well  as in  the presence of 
cAMP-elevating  agents  as  judged  by  measurement  of  [3H]colchicine  binding  of  total  and 
pelletable  tubulin.  The  involvement  of  cAMP  was  revealed  by  increasing  its  endogenous 
production  by cholera toxin or by treatment with 8BrcAMP. The enhancing effects of antimi- 
crotubule drugs and cAMP-elevating agents could be demonstrated by incorporation of [3H]- 
thymidine  into acid-insoluble material, autoradiography of labeled nuclei, or flow cytofluoro- 
metric analysis. The addition of antimicrotubule drugs does not increase the intracellular level 
of cAMP nor does addition of cAMP-elevating agents promote disassembly of microtubules (as 
judged  by measuring  [3H]colchicine  binding of  total  and  pelletable  tubulin)  in  3T3 cells.  In 
view of these findings and the striking synergistic effects between these agents in stimulating 
DNA synthesis in the presence of a peptide growth factor, we conclude that increased cAMP 
levels  and  a  disrupted  microtubule  network  regulate  independent  pathways  involved  in 
proliferative  response. 
Quiescent 3T3 cells resting in the Go/G~ phase of the cell cycle 
can be stimulated to reinitiate DNA synthesis when combina- 
tions of growth-promoting factors that act synergistically are 
added to cultures maintained in serum-free medium (31,  32). 
Understanding  the mechanisms whereby extracellular factors 
modulate cell proliferation requires identification of the intra- 
cellular signals important for initiating a  mitogenic response. 
Recent work from this laboratory has shown that an increase 
in the cellular level of cAMP acts synergistically with insulin 
and other growth-promoting agents to stimulate quiescent cul- 
tures of 3T3 cells to reinitiate DNA synthesis and cell division 
(33-36).  The  elevated  cAMP  levels  were  induced  by either 
increasing  its  endogenous  production  by cholera  toxin  (36), 
adenosine agonists, (34) or prostaglandin  E1 (33) or by exoge- 
nous  addition  of cAMP  derivatives,  such  as  8BrcAMP  (35). 
The mitogenic effectiveness of these compounds was markedly 
potentiated by inhibitors of  cyclic nucleotide phosphodiesterase 
(33'36). These findings suggest that a sustained increase in the 
intracellular level of cAMP acts as one of the mitogenic signals 
for Swiss 3T3 ceils. 
Several other  studies  suggest  that  changes  in  the  state  of 
organiTation  of the  cytoplasmic  microtubules  may  act  as  a 
signal in the regulation of the transition of cells from Go/G1 
phase to DNA synthesis. In cultures of 3T3 cells, disruption of 
the microtubular network with colchicine or other antitubulin 
agents  markedly  enhances  the  DNA  synthetic  response  to 
various growth-promoting factors including epidermal growth 
factor (EGF), and insulin (13-15, 24, 26, 39), fibroblast-derived 
growth factor (FDGF,  13,  15), platelet-derived growth factor 
(PDGF, 8), phorbol esters (7), and vasopressin (7). In addition, 
microtubule stabilization by taxol inhibits initiation of DNA 
synthesis by EGF (5). Thus, disassembly of cytoplasmic micro- 
tubules  can  enhance  the  stimulatory  effect  of a  variety  of 
mitogenic agents in fibroblastic cells. 
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organization in cell regulation has been the subject of consid- 
erable literature. Because increased levels of cAMP can change 
the arrangement  and length of microtubules (3,  9, 21,  27,  38, 
42) and since antimicrotubule drugs block a  variety of ceUular 
effects of cAMP  (16,  18,  19,  22,  28,  29),  it is plausible that a 
change (increase or decrease) in the state of organization of the 
mierotubules  may  play  a  necessary  role  in  modulating  or 
mediating  several  cellular  actions of cAMP.  Conversely,  the 
fact that disruption of microtubules markedly  potentiates the 
effect  of various  hormones  in  increasing  cAMP  levels  in  a 
variety of cell types (17,  20,  23,  30,  37)  raises the possibility 
that certain cellular effects of antimicrotubule  drugs could be 
mediated  by  cAMP.  Thus,  microtubules  may  play  a  role  in 
mediating  certain  actions  of cAMP  and,  conversely,  certain 
effects of antimicrotubule drugs could be exerted via cAMP. 
Since  both  cAMP-elevating  agents  and  antimicrotubule 
drugs stimulate events leading to initiation of DNA  synthesis 
in  3T3  cells  (see  above),  it  was  of importance  to  determine 
whether these agents could have opposite, synergistic, or com- 
mon steps in their mechanism of mitogenic action. The exper- 
iments presented here were designed to examine the interaction 
of microtubules and cAMP  in modulating  the stimulation of 
DNA  synthesis in 3T3 cells. 
MATERIALS  AND  METHODS 
Cell Culture:  Swiss  3T3 mouse cells (41) were propagated  in 90-ram 
Nunc Petri dishes in Dulbecco's  modified  Eagle's medium (DME),  10% fetal 
bovine serum, 100 U/ml penicillin, and 100/~g/ml streptomycin in a humidified 
atmosphere of 10% CO2 and 90% air at 37°C. Cells were subcoltured at 10  s in 30- 
mm Nunc Petri dishes with DME containing  10% fetal bovine serum. After 6 d, 
the cultures became  confluent  and quiescent  at G0/G1 phase.  Such quiescent 
cultures  were  washed  twice  with  DME  at  37°C  to  remove  residual  serum 
immediately pr~edlng experiments  with  growth factors. 
Incorporation of [a H]Thymidine into DNA:  Confluent and 
quiescent cultures of Swiss 3T3 cells in 30-ram Nunc Petri dishes were washed 
twice with DME at 37"C. Then the cultures were incubated  in 2 ml of a  1:1 
mixture of DME and Waymouth medium (25) containing [3H]thymidine (TdR: 1 
#M,  1 #Ci/ml) and various agents as indicated. After 40 h at 37°C, [aI-I]TdR 
incorporation  into acid-insoluble pools was assayed as follows: cultures  were 
washed twice with phosphate-buffered  saline (PBS) (0.15 M NaC1 in 0.01 M 
KzPO4 buffer, pH 7.4), and acid-soluble radioactivity was removed by a 20-rain 
exposure to 5% triehloroacetic acid (TCA) at 4°C. The acid-insoluble material 
remaining on the dishes was washed twice in alcohol, and then solubilized by a 
30-rain incubation  with 0.1  M NaOH/2% NasCOa, and the radioactivity  was 
assayed (7). 
Flow Cytofluororaetric Assay:  Cem were detached  by minimal 
treatment  with trypsin (0.025%) and 0.4 mM EDTA, suspended in DME con- 
tainlng 10% bovine serum, centrifuged at 1,000 rpm for 2 rain, washed twice with 
PBS, suspended in I ml of  saline, and rapidly squirted through a 25-gauge needle 
into 3 ml at a 70:30 ratio of ethanol/saline.  This suspension could be stored at 
4°C for  1-2 wk.  Immediately  before a  cytofluorometric  assay, the ethanohc 
suspension was subjected to centrifugation at 1,000 rpm for 2 rain and the cell 
pellet was resuspended in 0.5 ml of  a mixture containing 50/~g/ml of  mithramyein 
in a 25:75 ratio of ethanol/water plus 15 mM MgCls (40). After 30 rain, DNA 
histograms were obtained  with a Fluorescence Activated Cell Sorter (Becton- 
Dickinson & Co., Oxnard, CA). 
cAMP Radioimmunoassay:  Confluent  and quiescent  cultures  of 
Swiss 3T3 cells in 30-ram dishes were washed twice with DME at 370C and then 
incubated in 2 ml of DME/Waymouth medium in the presence  of various 
additions and for various times. At the end of  the specified incubation period, the 
medium was rapidly removed and cAMP was extracted with 200/xl of  0.1 M HCI 
(4). After 20 rain, the HC1 solution was neutralized and the precipitated protein 
remaining  on the dish was dissolved in  1 ml of 0.1  M NaOH/2% Na2COa. 
Appropriate dilutions of the neutralized HC1 extract were acetylated and cAMP 
was determined in dupheate by radioimmunoassay. 
Tubulin Assay:  The fraction of the total intracellular pool of tubulin 
present as polymerized microtubules was measured as described by Eichhom and 
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Peterkofsky (10, 11). Briefly, the medium was rapidly removed and replaced by 
0.2 ml of  microtubule-stabilizing medium 0dTM) (12) consisting of  50% glycerol, 
10% dimethylsulfoxide, 5 mM sodium phosphate, 5 mM MgCI~, pH 6.9, at 22°C. 
The cells were harvested by scraping, four dishes were pooled, and the suspension 
was sonieated at room temperature.  The sonicate was centrifuged at 100,000 g 
for 60 rain at 22°C to pellet the intact microtubules. The supernate was removed 
and the recovered pellet was resuspended in 100 pl of  ice-cold PM buffer (10 mM 
sodium phosphate,  10 mM MgCI2, pH 6.9) with 1 mM guanosine triphosphate 
and 0.5% Triton X-100 and then resonicated at 0°C to ensure total disruption of 
the microtubules (10). Tubulin in this solution was measured by the [aH]colchicine 
binding  assay  using  DEAE-cellulose  ftlters  as described  by Borisy (1). For 
determination  of the total cell tubulin  pool, duplicate  dishes were treated  as 
described above, except that MTM buffer was replaced by PM and sonication 
was performed at 0*C to insure that all tubulin would be soluble. These values 
and those obtained from the MTM-treated  samples were used to obtain the 
percentage of total tubulin polymerized into microtnbules. 
Indirect Immunofluorescent Staining:  swiss  3T3  cells were 
grown on 10-ram glass coverslips. After the cells were incubated with drug for 
the desired time, the coverslips were washed three times in PBS and fLxed  in 2.5% 
(wt/vol) glutaraldehyde  at 37"C for 20 rain. The coverslips were washed with 
PBS, treated with 0.1 M glycine for 10 rain, and then with 0.1% Triton X-100 for 
2 rain. The coverslips were covered with  15 #1 of rabbit antiserum  to tubulin 
(kindly provided by Dr. R. Brooks, Imperial Cancer Research Fund) that was 
diluted  1:10 in PBS. After 60 rain at 370C in a  humidified  atmosphere,  the 
coversllps were extensively washed with PBS, drained, and covered with 15/1.1  of 
rhodamlne-conjugated goat antiserum to rabbit immunoglobulin G for 60 rain at 
37"C, rinsed with PBS, mounted on glass slides in a drop of PBS/glyeerol (1:9), 
and examined with a Zeiss photomicroscope. 
Materials:  Bovine  insulin  (25.5 international  U/rag),  cholera  toxin, 
8BrcAMP, culchicine, demecoleine, vinblastine  sulfate, and nocodazole were 
purchased from Sigma Chemical Co., St. Louis, MO. 3-1sobutyl-l-methyl-xan- 
thine (IBMX) was obtained from Aldrich Chemical Co., Inc., Milwaukee, WI. 
PDGF was partially  purified  (700-fold) by sulfadex gel chromatography  and 
heating as described by Deud et al. (6). FDGF was partially purified as previously 
described  (2). [3H]thymidine (20 Ci/mmole), [SH]colehicine (37.2 Ci/mmole), 
and antigens and antibodies for radioimmunoassay of  cAMP were obtained from 
New England Nuclear (Boston, MA). 
RESULTS 
Effect of cAMP-elevating Agents, 
Antimicrotubule  Drugs, and Peptide Factors on 
[3H]TdR Incorporation  by 3T3 Cells 
To determine the interaction between the intracellular levels 
of cAMP  and the state of organization of the microtubules in 
modulating the initiation of DNA  synthesis in Swiss 3T3 cells, 
confluent and quiescent cultures of these cells were transferred 
to medium  supplemented with insulin, cholera toxin, or both 
and exposed to various concentrations of the antitubulin agents 
colchicine,  vinblastine,  demecolcine,  and  nocodazole.  As 
shown  in  Fig.  1,  addition  of antimicrotubule  drugs  in  the 
absence or presence of cholera toxin was not sufficient to elicit 
a  proliferative  response in cultures  maintained in serum-free 
medium.  However,  microtubule-disrupting  agents  caused  a 
marked and dose-dependent enhancement of the incorporation 
of [3H]TdR into acid-insoluble material when added to cultures 
stimulated by both cholera toxin and insulin. Results identical 
to those shown in Fig.  1 were obtained when 8BrcAMP at 2 
mM  was added instead of cholera toxin (results not shown). 
In the experiments described in Fig.  1,  the interaction be- 
tween cAMP-elevating agents and antitubulin drugs was stud- 
ied in the presence of insulin.  Therefore,  it was of interest to 
determine whether insulin could be replaced by other growth- 
promoting factors. The experiment described in Fig. 2  shows 
that  a  marked  synergistic interaction between colchicine and 
cAMP-elevating agents can be demonstrated when vasopressin, 
FDOF,  PDGF,  or EGF  are added instead of insulin. es 
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FIGURE  1  Effect of colchicine, demecol- 
cine,  vinblastine,  and  nocodazole  on 
[aH]TdR  incorporation  into acid-precip- 
itable material in the presence of cholera 
toxin, insulin, or both  in Swiss 3T3  cells. 
Measurement  of  [3H]TdR  incorporation 
into acid-insoluble material after a 40-h 
incubation was done as described in Ma- 
terials and Methods. The final concentra- 
tion of the antitubulin agents was varied 
from 8 x  10 -s to 5 x  10 -6 M  as indicated. 
A, 100 ng/ml  of cholera toxin; O, 1/zg/ 
ml  of  insulin;  @,  100  ng/ml  of  cholera 
toxin plus 1/~g/ml of insulin. 
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FIGURE  2  Synergistic  effects  of 
colchicine  and  cAMP-elevating 
agents  in  stimulating  DNA  syn- 
thesis  in  the  presence  of  vaso- 
pressin, EGF, FDGF, or PDGF. The 
concentrations  of  the  rnitogens 
were 20 ng/ml,  S ng/ml, 5/~g/ml, 
and  3.5  /~g/ml  for  vasopressin, 
EGF,  FDGF,  and  PDGF,  respec- 
tively.  Measurement  of  [3H]TdR 
incorporation  into  acid-insoluble 
material  after  a  40-h  incubation 
was  done  as  described  in  Mate- 
rials and Methods. 
Stimulation of 3T3 Cells as Revealed by 
Autoradiography and by Flow 
Cytofluorometric  Analysis 
It was important to assess whether cAMP-elevating agents, 
antimicrotubule  drugs,  and insulin  interact  synergistically  in 
eliciting initiation of DNA replication rather than in changing 
the specific activity of the [3H]TdR precursor pool. Quiescent 
cultures of 3T3 cells were treated with various combinations of 
insulin,  cholera toxin,  8BrcAMP,  IBMX,  and colchicine  and 
incorporation of [SH]TdR  into DNA was quantified by auto- 
radiography  of  labeled  nuclei.  As  can  be  seen  in  Fig.  3, 
colchicine enhances the labeling index of cultures treated with 
cAMP-elevating  agent and insulin either in the absence or in 
the presence of IBMX.  Since colchicine  added without other 
growth-promoting agents does not induce any significant DNA 
synthesis in Swiss 3T3 cells,  the interactions between cAMP- 
elevating agents and antimicrotubule drugs in the presence of 
insulin  shown in  Fig.  3  were  clearly synergistic  rather than 
additive. Similar results were obtained when the concentration 
of insulin was increased  10-fold (to 10/zg/ml). For example, in 
the presence  of 10 #g/mi  insulin,  the percentages  of labeled 
nuclei were 29 to 31% in cultures  treated with cholera toxin 
plus IBMX or 8BrcAMP plus IMBX, respectively; these values 
increased to 62 and 65%, respectively,  when paraUel  cultures 
(also  treated with cAMP-elevating  agents  and the  hormone) 
received  2.5/zM colchicine.  Thus,  colchicine  and cAMP-ele- 
vating agents  synergisticaliy  enhance  the  proportion  of cells 
that  enter  into  DNA  synthesis.  This  conclusion  is  further 
substantiated by experiments in which the cell cycle distribu- 
tion of the population was determined by flow cytofluorometric 
analysis.  In these experiments we exploited the fact that col- 
chicine  is  not effective  in enhancing  DNA synthesis  once  S 
phase has been initiated  but can block cell  cycle traverse  at 
mitosis  (14).  Initiation  of S  phase  in  cultures  of 3T3  ceils 
stimulated by cAMP-elevating  agents and insulin takes place 
after a lag of 17 h (35). As shown in Fig. 4, colchicine added 
simultaneously  with  8BrcAMP  plus  IBMX  or cholera  toxin 
plus IBMX to cultures incubated with insulin causes a marked 
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thesis assessed by autoradiography after a 40- 
h  incubation  in  cultures  of  Swiss  3T3  cells 
exposed to insulin and cholera toxin (left) or 
to insulin and 8BrcAMP (right) in the absence 
or in the presence of IBMX (X). The concen- 
trations  of  the  mitogens were  1 #g/ml,  100 
ng/ml, 2 raM, 10/~M, and 1/zM for insulin (I), 
cholera toxin ( 7),8BrcAMP (A), IBMX (X}, and 
colchicine (C), respectively. 
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enhancement in the proportion of cells in S plus G2 plus M  as 
compared with the cultures that received colchicine 20 h after 
the  addition  of cAMP-elevating  agents  and  insulin.  These 
findings are in agreement with the results shown in Fig. 3 and 
indicate that  antimicrotubule drugs, cAMP-elevating agents, 
and insulin, added at saturating concentrations, act synergisti- 
cally to stimulate entry into DNA synthesis to 3T3 cells. 
Effect of Colchicine on the Intracellular Content 
of cAMP in Swiss 3T3 Ceils 
Since disruption of microtubules could increase cAMP levels 
and potentiate cholera toxin-induced accumulation of cAMP 
as reported in a variety of other cell types (17, 20, 23, 30, 37), 
it is plausible that certain effects of these drugs are exerted via 
cAMP. To test this hypothesis, we have measured cAMP levels 
in quiescent 3T3 cells exposed to cholera toxin with or without 
IBMX in the absence or presence of colchicine. As shown in 
Table I, addition of cholera toxin (100 ng/ml) caused a fivefold 
increase in cAMP levels after a  3-h incubation; addition of 
colchicine did not alter the content of cAMP cultures incubated 
with cholera toxin either in the absence or in the presence of 
IBMX. Similar results were obtained when the cultures were 
incubated  for  1 or 24  h  instead of 3  h  (results not  shown). 
These results rule against the proposition that antimicrotubule 
drugs act in 3T3 cells by increasing the production of cAMP. 
Effect of cAMP-elevating Agents, 
Antimicrotubule Drugs, or Both on 
Cytoplasmic Microtubules 
The interpretation of the foregoing experiments relies on the 
important assumption that the antitubulin agents dissociate the 
microtubular network  in  cells treated  with  cAMP-elevating 
agents. To test this hypothesis, we determined the degree of 
organization of the microtubular network by applying a quan- 
titative biochemical procedure for recovering and measuring 
intact sedimentable microtubules. Polymerized and depolym- 
erized states of tubulin in cellular homogcnates were preserved 
in a stabilizing medium (12), separated by centrifugation and 
quantified with a  [aH]colchicinc binding assay (1,  10,  l 1). As 
shown in Fig. 5 (left), exposure of 3T3 cells to various concen- 
trations of nocodazole leads to a dose-dependent decrease of 
the fraction of cellular tubulin present in the polymerized form 
(microtubules). The half-maximal concentration derived from 
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FIGURE  4  Flow cytofluorometric DNA histograms showing the ef- 
fect of 2.5/~M colchicine on the progress from G1 to S phase in Swiss 
3T3 cells stimulated for 40 h simultaneously by 2 mM 8BrcAMP with 
1 /~g/ml insulin and 20/~M IBMX (A +  8) or 100 ng/m[ of cholera 
toxin with  insulin and IBMX (C 4-  D). Colchicine was added 20 h 
after the other agents as a control (A and C) or at the start of the 40- 
h  incubation  (B and D). Flow cytofluorometry was carried out as 
described in Materials and Methods. In each case, the DNA in the 
right-hand  peak (G2 phase) is equivalent to twice the DNA in the 
Gl-phase to the left. Values for S 4- G2 4- M  (percentages) were: (A) 
13.2 + 4.2, (B) 41.5 + 5.8, (C) 23.5 :t: 2.9, and (D) 40.4 + 0.4. 
Fig.  5  (0.1  #M)  is  in  reasonable  agreement  with  the  half- 
maximal concentration  of nocodazole that  caused  enhance- 
ment of DNA synthesis stimulated by cholera toxin and insulin 
(0.15 #M, Fig. l) or by 8BrcAMP and insulin (0.1/tM, results 
not  shown). 
To check whether the antitubulin agents are able to induce 
microtubule disassembly in cells treated with cAMP-elevating 
agents, quiescent cultures of Swiss 3T3 cells were treated with 
cAMP-elevating agents for 24 h  and then exposed to 0.5 #M 
nocodazole for 1 h. As shown in Fig. 5 (fight), cAMP-elevating agents cause a small increase rather than a decrease in the state 
of polymerization  of cellular  tubulin.  Similar  results  were 
obtained  when  the  cells  were  treated  with  cAMP-elevating 
agents for 1 or 18 h  instead of 24 h. Addition of nocodazole 
markedly reduced the proportion of organized tubufin either 
in the absence or in the presence of cAMP-elevating agents. A 
similar result was obtained when microtubules were visualized 
by  immunofluorescence  with  a  specific  antibody  directed 
against tubulin (Fig. 6). The immunofluorescent staining pat- 
tern of 3T3 cells  shows an abundant  array of microtubules 
both in the absence (Fig. 6, upper) and in the presence (Fig. 6, 
middle)  of cholera  toxin,  and  is  virtually  identical  to  that 
published by Brinkley et al.  (3).  When cholera toxin-treated 
3T3  cells  were  exposed  to  nocodazole  (Fig.  6,  lower),  the 
filaments essentially disappeared and the cells lost their fibro- 
blastic  shape.  Thus,  nocodazole  reduced  the  proportion  of 
org~nlzed tubulin in either the absence or presence of cAMP- 
elevating agents, as judged by measuring [~H]colchicine  bind- 
ing  of total  and  pelletable  tubulin  as  well  as  by  indirect 
immunofluoresccnce. 
Effect of Removal or Delayed Addition of 
Nocodazole on DNA Synthesis Stimulated by 
Cholera Toxin and Insulin 
In an attempt to determine which stage during the transition 
of cells from Go/Gz to S phase was enhanced by disruption of 
TABLE  I 
Effect of Colchicine, Cholera Toxin, and IBMX on cAMP 
Content in 3T3 Cells 
Additions  cAMP content 
Colchicine 
Cholera toxin 
Cholera toxin +  colchicine 
Cholera toxin +  IBMX 
Cholera toxin +  IBMX +  colchicine 
pmol/mg protein 
9.4 4- 1.5 (12) 
4.6 4- 0.9 (12) 
46.6 + 3.9 (9) 
44.3 ±  8.'[  (12) 
79.7 +  6.2  (12) 
77.6  ± 5.6 (12) 
Quiescent cultures  of Swiss 3T3 cells were exposed to colchicine  (2.5 ~M), 
cholera toxin (100 ng/ml), IBMX (10/~M), or their combinations for 3 h. The 
experimental conditions and the measurements of cAMP were as described 
in Materials  and Methods. 
rnlcrotubules, quiescent 3T3 cells were incubated with cholera 
toxin plus insulin for 48 h, but transiently exposed to nocoda- 
zole for various periods of time from the onset of stimulation 
by the toxin and the hormone. The cultures were exposed to 
[3H]TdR (present from time zero and added again with cholera 
toxin and insulin  after the wash to remove the nocodazole) 
throughout the 48-h incubation. Nocodazole (rather than col- 
chicine) was used in these experiments because this drug can 
be more completely removed by washing (15, 43), which offers 
obvious advantages in analyzing the temporal relations of its 
effects.  As shown in Fig. 7 (A), a 4-h exposure of the cells to 
nocodazole followed by washing of the cells was not effective 
in enhancing DNA synthesis. In contrast, an 8-h exposure to 
nocodazole produced a substantial enhancement of DNA syn- 
thesis.  These findings suggest that disruption of microtubules 
is effective in stimulating DNA synthesis by cholera toxin and 
insulin  when  induced  in mid  G1  phase.  This  conclusion is 
further substantiated by experiments in which nocodazole was 
added at vaxious times after cholera toxin and insulin. Fig. 7 
(Z~) shows that the addition of nocodazole can be delayed up 
to 4 h  after addition of toxin and hormone to quiescent 3T3 
cells without any diminution of enhancement of DNA synthe- 
sis.  These  findings  suggest  that  disruption  of microtubular 
network is required several hours after the initial interaction of 
the mitogeuic agents with the cell. 
DISCUSSION 
Recently, it has been demonstrated that both an increase in the 
intracellular  level of cAMP (33-36)  and a  disruption  of the 
microtubular network (7, 8, 13-15, 24, 26) markedly potentiate 
the DNA synthetic response of 3T3 cells to various growth- 
promoting factors.  Because cyclic nucleotide generation and 
microtubule assembly-disassembly are interrelated in a variety 
of cell types, it was of importance to examine whether micro- 
tubules and cAMP modulate the initiation of DNA synthesis 
in 3T3 ceils by common or separated pathways. 
In theory, cAMP and microtubules may share common steps 
in their mechanism of mitogenic action.  Since disruption of 
cytoplasmic  microtubules  potentiates  the  accumulation  of 
cAMP in response to hormones and cholera toxin in a variety 
of cell types (17, 20, 23, 30, 37), it appeared feasible that the 
mitogenic effects of antimicrotubule agents in 3T3 celL~ could 
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FIGURE  ..5  Depolymerization  of cytoplas- 
mic  microtubules  by  various  concentra- 
tions of  nocodazole  (left)  or by  nocoda- 
zo[e in the absence or presence of cholera 
toxin plus IBMX (right). Cultures of quies- 
cent  Swiss  3T3  cells  were  washed  and 
transferred to medium  containing various 
concentrations of nocodazole for 2 h ([eft). 
In a separate experiment, the cultures were 
incubated with 100 ng/ml of cholera toxin 
plus  20/~M  IBMX for 24  h  and  then  ex- 
posed  to 0.5/~M  nocodazole for an addi- 
tional  1  h  (right).  The  fraction  of  total 
cellular tubulin in 3T3 cells present as sed- 
imentable microtubules  was measured  as 
described under Materials and Methods. 
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3T3 cells using antibodies directed against tubu- 
lin.  Upper, control cell;  middle, Swiss  3T3 cells 
treated with  100 ng/ml  of cholera toxin plus 20 
/~M IBMX for 24 h; lower, cultures incubated with 
cholera toxin and IBMX for 24 h and then exposed 
to  2.5 /~M  nocodazole for  an  additional  1  h.  x 
600. 
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Effect  of  addition  or removal of  nocodazole at various 
times on its ability to enhance [SH]thymidine incorporation in 3T3 
cells continuously exposed to insulin and cholera toxin. Quiescent 
Swiss 3T3 cells were transferred to insulin  (200 ng/ml)  and cholera 
toxin (30 ng/ml;  t = 0). Then, nocodazole (2.5 #M) was added at the 
time  shown  (A).  Other  cultures  of  3T3  cells  were  exposed  to 
nocodazole, insulin, and cholera toxin for the time shown, washed 
with 1:1  DME/Waymouth  medium, and then incubated again with 
insulin and cholera toxin but without nocodazole (&). As controls, 
parallel cultures incubated with insulin and cholera toxin with  (O) 
or  without  (0)  nocodazole were subjected  to the  same washing 
procedure  at  the  time  shown,  but  after  this,  they  received  an 
identical  medium.  All  the  incubations  were  terminated  at  48  h, 
[aH]TdR was present throughout. The 48-h value was obtained with 
continuous exposure without any wash. 
be exerted via cAMP. However, this hypothesis is not supported 
by the fact that colchicine failed to increase cAMP levels in 
3T3  cells  when  added  in  either  the  absence  or  presence  of 
cholera  toxin  alone  or  with  IBMX  (Table  I).  In  addition, 
antimicrotubule  drugs  enhanced  mitogenesis  induced  by 
8BrcAMP; this provides further support to the proposal that 
microtubule disassembly acts at a step distal to cAMP genera- 
tion. 
An alternative possibility that would be consistent with the 
hypothesis that cAMP and microtubules share common steps 
in their mitogenic action is that cAMP, like the antimicrotubule 
drugs,  promotes dissolution of the cytoplasmic microtubules 
(38).  This interpretation was not substantiated  by direct bio- 
chemical measurements of polymerized tubulin in cultures of 
3T3 cells. We found that cAMP-elevating agents cause a small 
increase rather than a decrease in the state of polymerization 
of tubulin  in  3T3 cells.  This  observation is  in line with the 
findings  of Eichhorn  and  Peterkofsky (10)  with  virus-trans- 
formed 3T3 cells. A similar conclusion was obtained when the 
microtubules were visualized by indirect immunofluorescence. 
All these  results  are  not consistent with  the  hypothesis that 
cAMP and dissassembly of microtubules enhance mitogenesis 
in  3T3  cells  via a  common or overlapping mechanism;  The 
antimicrotubule drugs do not increase the production of cAMP 
nor  do  the  cAMP-elevating  agents  promote  disassembly  of 
microtubules in these cells. 
An  alternative  hypothesis  is  that  cAMP  and  microtubule 
disassembly  regulate  separate  (rather  than  common)  events 
that signal initiation  of DNA synthesis in the presence of a 
peptide factor. Evidence in favor of this interpretation comes 
from experiments in which disruption of the microtubule net- 
work, cAMP-elevating agents, and peptide factors act synergis- 
tically to stimulate the entry into DNA synthesis of 3T3 ceils. 
These synergistic effects could be demonstrated by incorpora- 
tion of [aH]TdR into acid-insoluble material, autoradiography 
of labeled nuclei, or flow cytofluorometric analysis. 
The involvement of the microtubules in the enhancement of 
the DNA synthetic response was demonstrated with the chem- 
ically  diverse  agents  colchicine,  nocodazole,  vinblastine,  or 
demecolcine, all of which were found to elicit the response in 
a dose-dependent manner. We verified that at the doses used 
in this study nocodazole induced microtubule disassembly in 
either  the  absence or presence of cAMP-elevating agents  as 
judged by measuring [ZH]colchicine  binding of total and pel- 
letable  tubulin  or by indirect  immunofluorescence.  The fact 
that cAMP was active in synergistically stimulating mitogenesis 
in 3T3 cells without polymerized tubulin further suggests that 
the action of the cyclic nucleotide is not mediated by a change 
in the state  of organization of the  microtubules.  Additional 
support  for the  hypothesis  that  cAMP  and  antimicrotubule 
drugs  control different  events  leading  to  initiation  of DNA 
synthesis comes from the fact that cAMP and disassembly of 
microtubules appear to act at different points of the Gx phase; 
cAMP-elevating agents were demonstrated to be required  in 
early G1 phase (35),  whereas  antimicrotubule  drugs are  still 
effective  in  enhancing  DNA  synthesis  when  added  several 
hours after the initial interaction of the mitogenic agents in the 
cell, i.e., in mid-Gx phase. 
Understanding the mechanisms whereby extracellular agents 
modulate cell proliferation requires identification of the intra- 
cellular signals important for initiating a mitogenic response. 
We conclude that cAMP and microtubule disassembly consti- 
tute separate mitogenic signals that are elicited by different sets 
of extracellular agents. In confluent and quiescent Swiss  3T3 
cells,  neither of these signals is sufficient to induce a prolifer- 
ative  response  in  serum-free medium.  However, when these 
signals are elicited in the presence of other growth-promoting 
factors, they act synergistically to stimulate exit from Go phase 
and entry into DNA synthesis in 3T3 cells. The multiple control 
of initiation  of DNA  synthesis  in  3T3  cells  by identifiable 
internal signals provides a model for understanding the mech- 
anisms by which extraceilular factors may regulate cell prolif- 
eration. 
Received for  publication  10  September  1982,  and  in  revised form  14 
February  1983. 
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